Geron (GERN) Cash from Operations (2010 - 2026)
Geron's (GERN) quarterly Cash from Operations came in at 62906000.0 in Q1 2026, down 31.11% year-on-year from 91315713.84 in Q1 2025, and down 185.07% quarter-over-quarter from 22067000.0 in Q4 2025.
Geron (GERN) Cash from Operations (2010 - 2026) Analysis & Trends
Geron has disclosed Cash from Operations across 17 years of filings, most recently posting 62906000.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 62906000.0, down 31.11% year-over-year; the trailing twelve-month figure through Mar 2026 was 125964000.0 (up 38.36% YoY), and the FY2025 annual result was 111037000.0, up 49.21% from the prior year.
- Cash from Operations came in at 62906000.0 for Q1 2026 at Geron, down from 22067000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 13576000.0 in Q3 2025 to a low of 62906000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 40938000.0 (2023), against an average of 40451941.18.
- Across the five-year window, Cash from Operations plunged 80.66% in 2024 and soared 76.97% in 2025, its largest moves.
- Geron's Cash from Operations stood at 35181000.0 in 2022, then retreated by 16.36% to 40938000.0 in 2023, then fell by 7.35% to 43945000.0 in 2024, then jumped by 49.78% to 22067000.0 in 2025, then tumbled by 185.07% to 62906000.0 in 2026.
- The last three Cash from Operations figures came in at 62906000.0 (Q1 2026), 22067000.0 (Q4 2025), and 13576000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - | -62.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.91 Mn |
| Mar 31, 2026 | -62.91 Mn |
| Dec 31, 2025 | -22.07 Mn |
| Dec 31, 2025 | -22.07 Mn |
| Sep 30, 2025 | -13.58 Mn |
| Sep 30, 2025 | -13.58 Mn |
| Jun 30, 2025 | -27.42 Mn |
| Jun 30, 2025 | -27.42 Mn |
| Mar 31, 2025 | -47.98 Mn |
| Mar 31, 2025 | -47.98 Mn |
| Dec 31, 2024 | -43.95 Mn |
| Dec 31, 2024 | -43.95 Mn |
| Sep 30, 2024 | -58.94 Mn |
| Sep 30, 2024 | -58.94 Mn |
| Jun 30, 2024 | -53.48 Mn |
| Jun 30, 2024 | -53.48 Mn |
| Mar 31, 2024 | -62.25 Mn |
| Mar 31, 2024 | -62.25 Mn |
| Dec 31, 2023 | -40.94 Mn |
| Dec 31, 2023 | -40.94 Mn |